AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04699929 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YH001
Description: YH001 will be administered intravenously over 60minutes every three weeks (Q3W) for up to 1 years .
Study NCT04731727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riboflavin
Description: Corneal cross linking achieved by combination of Riboflavin and ultraviolet light
Study NCT04991246 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antigenic tests (on saliva samples)
Description: SARS-CoV-2 screening tests: two massive antigenic tests campaigns (on salivary samples).
Study NCT05117463 — intervention group
Intervention type: OTHER
Intervention: Optic Flow Stimulation
Description: The optic flow will be displayed at different speeds. The subject will need to look at the center of the optic flow.
Study NCT05117463 — intervention group
Intervention type: OTHER
Intervention: Auditory Reaction Time
Description: Two different pitches of tones will be played. The participants will need to press a button on the right or left hand based on the pitch of the tone.
Study NCT05569265 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraoperative hemodynamic management
Description: Goal directed Hemodynamic therapy
Study NCT05121649 — intervention group
Intervention type: OTHER
Intervention: Video streaming
Description: Video streaming as a supplement to telephone during emergency calls for dispatchers at EMCCs
Study NCT04991246 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individual electronic sensor port
Description: Individual electronic sensor recording contacts but not their location (in the form of a bracelet, a key ring or a badge) Contact data collection points (5 maximum, located at compulsory passage points for participants). When a sensor is close to one of these terminals, it discharges its contacts in seconds.
Study NCT04991246 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Atmospheric measurements of CO2
Description: Atmospheric measurements of CO2 in the relevant closed places of the faculty (lectures / practical work / BU / refectory): battery operated sensors. When a sensor is installed in a place, the ventilation conditions (number of open windows, etc.) as well as the number of people present will be noted.
Study NCT06389071 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional 2940 nm Laser
Description: Fractional 2940 nm Laser
Study NCT05256836 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tablet computer-based cognitive training program
Description: The subject of the study executes a program mounted on a tablet personal computer (PC) (Samsung Galaxy Tab S6 Lite) and performs a cognitive training task by touching the screen with the index finger.~It consists of 10 tasks related to the activity of daily living: 1) taking medicine, 2) making a phone call, 3) taking a shower, 4) doing laundry, 5) finding directions, 6) riding the bus, 7) buying goods, 8) Money management, 9) ingredient sorting, 10) meal preparation.~It is involved in cognitive functions in various domains such as attention, working memory, processing speed, problem solving, visuospatial ability, verbal and visuospatial memory.~There are three levels of difficulty for each task, high, medium, and low, and the difficulty becomes more difficult as session 1 to 36 progresses.~One cognitive training session lasts about 30 minutes.
Study NCT04285671 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Necitumumab
Description: Given IV
Study NCT04285671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Given PO
Study NCT04285671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04285671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04285671 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Given IV
Study NCT05696691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: 100mg IM ketamine to be administered in conjunction with CRP. The ketamine injection will be administered first. Participants will be observed and have vital signs monitored for the first 45 minutes after administering medication in the ED, observing for immediate reactions. Afterwards, participants will continue to be monitored for potential late-term side effects on the inpatient unit. Ketamine will be given only after initial standard of care (SOC) treatment and screening studies have been initiated.
Study NCT05696691 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Crisis Response Plan
Description: Crisis Response Plan is a brief, empirically-validated, Cognitive-Behavioral Therapy-based one-time therapy, and its administration typically takes 30-60 minutes. It begins with a narrative assessment (allowing patients to tell their story) and concludes with collaboratively constructed plan that outlines strategies for the patient's self-management of future acute suicidal crises. Patients who engage in CRP are given an index card to keep with them that summarizes the emotional management strategies that they collaboratively generate with the CRP provider.
Study NCT06159946 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Access-H2O faucet
Description: The assigned invention was developed to test the feasibility of the prototype of the Access-H2O faucet by assessing whether subjects can activate the faucet to control water outputs via the motion sensor, eye gaze, and a speech speaker. To activate the faucet via the motion sensor, each subject was asked to place his or her hand near the motion sensor. To activate the faucet via the eye gaze, each subject was asked to look directly at the eye gaze sensor. To activate the faucet via the speech speaker, each subject was asked to speak to the speaker. Each subject performed the same function three times. The water from the faucet was used for drinking, rinsing, and grooming.
Study NCT06286878 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will be randomized to use dapagliflozin or placebo in a double-blind way
Study NCT06286878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Patients will be randomized to use dapagliflozin or placebo in a double-blind way
Study NCT06561048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Soquelitinib
Description: Soquelitinib 200 mg tablets will be taken by mouth two times a day
Study NCT06561048 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Belinostat
Description: Belinostat (1000 mg/m2) will be administered by intravenous infusion once daily on Days 1 through 5 of each 21-day cycle
Study NCT06561048 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pralatrexate
Description: Pralatrexate (30 mg/m2) will be administered intravenously over 3 to 5 minutes once weekly for 6 weeks in each 7-week cycle
Study NCT05537259 — intervention group
Intervention type: OTHER
Intervention: Observation Group
Description: No intervention; this is an observational study.
Study NCT06455670 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sanhan Huayin recipe, Qingre Huatan recipe or Zaoshi Huatan recipe
Description: On the basis of conventional treatment of western medicine,the experimental group will be given Sanhan Huayin granule , Qingre Huatan granule or Zaoshi Huatan granule based on CM syndrome differentiation.Take 1 dose daily for 10 days.
Study NCT06455670 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sanhan Huayin recipe placebo, Qingre Huatan recipe placebo or Zaoshi Huatan recipe placebo
Description: On the basis of conventional treatment of western medicine, in the experimental group 5% of the placebo drug, color, smell, taste, appearance, weight, similar to the experimental drug, drug packaging and test group. One dose was given daily for 10 days.
Study NCT05607056 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sinquanon
Description: This probiotic food supplement includes fourteen probiotic bacterial strains of Lactobacillus Spp, Bifidobacterium Spp., Bacillus coagulans, Saccharomyces boulardii, three prebiotics and Vitamin-B complex - B1, B2, B3, B6, B7, B9 in an enterosolvent cellulose capsule. The product includes supplementary substances: maltodextrin and magnesium stearate.~2 capsules once a day during the antibiotic dosing. 1 capsule a day for 14 days following completion of antibiotic dosing.
Study NCT05607056 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo product will have the same appearance as the active product and the same composition but without the live bacteria, prebiotics, and vitamin-B complex. 2 capsules once a day during the antibiotic dosing. 1 capsule a day for 14 days following completion of antibiotic dosing.
Study NCT06439186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocain
Description: Local anesthesia
Study NCT05206123 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: Patients will be interviewed with a semi-structured qualitative interview in order to know how they lived their first sexual experiences and their sex lives during their adolescence
Study NCT05417685 — intervention group
Intervention type: DEVICE
Intervention: Acute and post-acute
Description: These programs will cover patients suffering from acute or post-acute musculoskeletal conditions including, but not limited to, shoulder pain (tendinitis/impingement/bursitis), neck pain, low back pain, knee or hip pain/osteoarthritis, which significantly impact their quality of life, to the extent they seek specialised care in direct relation to these disorders.
Study NCT04775160 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SmartSafe
Description: The SmartSafe Ecological Momentary Intervention is contained in the MEmind smartphone application and consists of a Safety plan, an Enhanced contact via app (app-EC) intervention, and a mental toolbox. The Safety plan is a set of personalized coping strategies that the patient can use in a suicidal crisis. Our safety plan was adapted to a digital environment, including the possibility to activate pre-recorded messages, lead to websites with health resources, or put the patient in contact with the emergency services. The Enhanced contact via app (app-EC) intervention is inspired by the SIAM project and consists in messages that will be sent via the MEmind app inquiring patients about their mental well-being and informing them of the means to request preferential or urgent care. The mental toolbox contains videos relaxation techniques videos and behavioral activation and mentalization exercises.
Study NCT05192239 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: THC 5
Description: 5 milligrams of THC in gummy form
Study NCT05192239 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Commercially available non-THC fruit snack
Study NCT04975711 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP2105
Description: Test drug
Study NCT04975711 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLD2104
Description: Reference drug
Study NCT05204992 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ultrasound guided hydrodissection
Description: Injection of steroids, saline and bupivicaine ultrasound guided
Study NCT04740450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: skin colored Kinesio-Tex Gold tape, 50 mm _ 5 m (Kinesio Holding Corp, Albuquerque, NM) tapped in technique described by Gozluklu et al in 2020
Study NCT04740450 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Wound Tape
Description: skin colored wound tape tapped in technique described by Gozluklu et al in 2020
Study NCT04856033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TM
Description: Transcendental Meditation instruction, 12-sessions over 3-4 months with monthly follow-up
Study NCT05420610 — intervention group
Intervention type: OTHER
Intervention: Control group: Patients being admitted when The advancement of transpulmonary thermodilution(TPTD) device was unavailable.
Description: The control group included patients being admitted when TPTD device was unavailable; and relatively stable patients without the need for TPTD. The adequacy of fluid resuscitation in the control group was monitored by traditional monitoring parameters including vital signs and hourly urine output.
Study NCT05420610 — intervention group
Intervention type: OTHER
Intervention: Study group: TPTD device was implemented for monitoring.
Description: TPTD device was implemented for monitoring; the inclusion criteria included patients suffering from 2nd degree burn greater than 40% TBSA; a combined 2nd to 3rd degree burn greater than 30% TBSA; or patients with inhalation injury despite the burned surface area.
Study NCT05417685 — intervention group
Intervention type: DEVICE
Intervention: Chronic
Description: These programs will cover patients suffering from chronic musculoskeletal conditions including, but not limited to, shoulder pain (tendinitis/impingement/bursitis), neck pain, low back pain, knee or hip pain/osteoarthritis, which significantly impact their quality of life, to the extent they seek specialised care in direct relation to these disorders.
Study NCT05417685 — intervention group
Intervention type: DEVICE
Intervention: Post-surgical
Description: These programs will cover patients submitted to surgery for a given musculoskeletal condition, including, but not limited to, shoulder tendon repair, shoulder replacement, spinal surgery, hip or knee replacement, meniscal repair, knee ligament reconstruction, undergoing physical rehabilitation programs after surgery.
Study NCT06472297 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The continuous glucose monitoring system
Description: CGM device worn on back of the arm and glucose readings are shown on the participant's smartphone as a continuous data stream.
Study NCT06336629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Winlevi (clascoterone) 1% & Duac gel
Description: Participants will use Winlevi (clascoterone) 1% and Duac gel as per label
Study NCT06499272 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional occupational therapy sessions + NeuronUP
Description: Occupational therapy sessions are based on cognitive stimulation, manipulative skill training and psychomotor skills. In addition, 2 sessions per week are conducted with two Nintendo Switch games.
Study NCT06499272 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional occupational therapy sessions
Description: Occupational therapy sessions are based on cognitive stimulation, manipulative dexterity training and psychomotor skills.
Study NCT04812886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epidemiological study
Description: Questionnaires (quality of life, gout, life habit, comorbidities) anthropometrics and health measures DNA analysis RNA analysis Metabolomic analysis
Study NCT04856033 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PCT
Description: Present Centered Therapy, 12-sessions over 3-4 months with monthly follow-up
Study NCT06367751 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ctDNA measurement
Description: Blood samples are collected as part of standard of care and ctDNA measurements will be performed on these samples.
Study NCT06178276 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: behavior
Description: behavioral measurements will be performed during the oral comprehension testing
Study NCT06178276 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: physiology
Description: physiologic (autonomic) measurements will be performed during the oral comprehension testing
Study NCT06178276 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: imaging
Description: central (brain) measurements will be performed during the oral comprehension testing
Study NCT04755088 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib
Description: Subjects to receive Surufatinib 300mg on Day 1
Study NCT04861688 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Chinese Medicine (NeuroAiD II™ (MLC901)
Description: NeuroAiD II™ (MLC901) contains the extracts of 9 botanical active ingredients blended with commonly used excipients. The 9 botanical active ingredients are traditional herbs well documented in the Pharmacopoeia of the People's Republic of China.
Study NCT04861688 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo with same appearance as active intervention
Study NCT04612712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib Tosilate Tablets
Description: In the dose exploration phase (phase I) : three doses of Donafenib tosylate tablets \[50 mg twice a day; 100 mg twice a day; 200 mg twice a day \] will be explored. In the dose expansion phase (phase II), patients with advanced hepatocellular carcinoma will be treated at the recommended dose for phase 2(RP2D).The RP2D will be determined by the dose escalation study.
Study NCT04612712 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KN046 Injection
Description: 5mg/kg Q3W
Study NCT06385509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jatenzo
Description: 237 mg JATENZO twice daily
Study NCT06468592 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tilted insertion of implants
Description: Using osteotomes, implants are inserted and tilted from 30° to 45° into the palatal direction from the maxillary sinus.
Study NCT06468592 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Straight insertion of implants
Description: The implants are inserted in an axial direction into the maxillary sinus according to Summers' traditional technique.
Study NCT05178069 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: : Placebo for Probiotic
Description: Capsule manufactured without active ingredients.
Study NCT05178069 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Lactobacillus Rhamnosus GG
Description: Probiotic nutritional supplement; Lactobacillus Rhamnosus G
Study NCT05445102 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: autogenous demineralized dentin graft as bone substitute in treatment of intrabony defect
Description: after extraction of tooth it will be grinded using hand bone mill and demineralized and placed in intrabony defect
Study NCT05372354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-92480
Description: Specified dose on specified days
Study NCT05372354 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CC-92480
Description: Specified dose on specified days
Study NCT05012462 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CM-1500
Description: The CM-1500 is a U.S. FDA cleared non-invasive monitoring device that simultaneously monitors five (5) parameters of a patient's body. A combination of these parameters is represented by a single number known as the Relative Index value.
Study NCT05012462 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CM-1600
Description: The CM-1500 is a U.S. FDA cleared non-invasive monitoring device that simultaneously monitors Bioelectrical Impedance, Photoplethysmography (PPG) Amplitude, ECG Amplitude and Skin Temperature. A combination of these parameters is represented by a single number known as the Relative Index value.
Study NCT05293093 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wheelchair Skills Training Program
Description: a standardized training method for users of manual and powered wheelchairs and it combines evidence on motor-skills learning with evidence on how to perform specific wheelchair skills. A recent systematic review and meta-analysis provided evidence that WSTP is a safe and effective intervention that has a clinically meaningful effect on powered wheelchair skill capacity, in particular for new wheelchair users. The WSTP has shown to be effective in several wheelchair-dependent populations and promising to be used in people with complex movement disorders. Yet, adaptation to the specific needs and capabilities of individuals with complex movement disorders is necessary as it has not been assessed in this population. During the 4-week training phase, the participants will receive 3 training sessions per week of 45 minutes, including exercises as described in the Wheelchair Skill Training Program Version 5.1.2
Study NCT05372354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tazemetostat
Description: Specified dose on specified days
Study NCT05372354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986158
Description: Specified dose on specified days
Study NCT05372354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Specified dose on specified days
Study NCT05372354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Specified dose on specified days
Study NCT05372354 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Specified dose on specified days
Study NCT04845867 — intervention group
Intervention type: DEVICE
Intervention: ISAR-M THYRO
Description: A diagnostic device for early detection of haemorrhage following thyroid surgery
Study NCT05111327 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structured guideline
Description: Students in the intervention group will receive more learning materials before study. The structured guideline will be used to facilitate students' learning in simulation by the facilitator.
Study NCT06042543 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Screening with HPV test
Description: Women aged 25-49 yrs will be screened with a validated HPV test. They will also provide urine samples for HPV test. Women HPV positive in either sample will be referred to colposcopy for disease ascertainment.